home / stock / hqh / hqh news


HQH News and Press, Tekla Healthcare Investors From 03/15/22

Stock Information

Company Name: Tekla Healthcare Investors
Stock Symbol: HQH
Market: NYSE

Menu

HQH HQH Quote HQH Short HQH News HQH Articles HQH Message Board
Get HQH Alerts

News, Short Squeeze, Breakout and More Instantly...

HQH - Sponsored Dividend Reinvestment Plans Can Allow For Discounted CEF Shares

This is one way closed-end funds can grow their total share count, contrary to the "closed" part of their structure. When utilizing a dividend reinvestment plan or DRIP, it is generally a win-win-win scenario for all involved. Many DRIPs are implemented in the same manner, with th...

HQH - BME: High Concentration In Large Cap Led To Huge Downfall

BME is highly concentrated on large caps, but it is yet to recover from the pandemic. It has low dividend yield, thus not suitable for income-seeking investors. Short- and medium-term returns are low when compared with its peers. For further details see: BME: High Concen...

HQH - FBT: A Long Term Hold If Done With Effective Hedging

FBT is a passive biotechnology ETF, which doesn’t pay any dividend. Baring the past one year, FBT’s price return has outperformed the S&P 500. Effective portfolio rebalancing may determine its future growth. For further details see: FBT: A Long Term Hol...

HQH - Tekla Healthcare Investors cuts dividend by 5.9% to $0.48

Tekla Healthcare Investors (NYSE:HQH) declares $0.48/share quarterly dividend, -5.9% decrease from prior dividend of $0.51. Forward yield 9.15% Payable March 31; for shareholders of record Feb. 25; ex-div Feb. 24. See HQH Dividend Scorecard, Yield Chart, & Dividend Growth. For further d...

HQH - XBI And IBB: Sell Technology And Buy Biotech, The Only Undervalued Non-Cyclical Growth Sector

The macroeconomic backdrop of Fed interest rate hikes is rapidly deflating overvalued technology companies and "crypto-collectibles." We expect the technology sector to underperform value and biotech. After the sell-off, biotech companies' valuation is close to the 2018 level even tho...

HQH - Tekla Life Sciences Investors: Buy For Steady, Quarterly Dividend

HQL pays quarterly dividends. Even during the pandemic, its performance has been better than its peers. Current prices look attractive. For further details see: Tekla Life Sciences Investors: Buy For Steady, Quarterly Dividend

HQH - My Latest Recession Prediction (and 3 Safe Funds Yielding Up to 5.8%)

As dividend investors—and closed-end fund (CEF) investors, specifically—we know to stay the course when market corrections hit: we don’t want to sell and cut off our precious payouts! That’s the opposite of the fanboys and girls who dabble in crypto, prof...

HQH - 2 Super Dividend Bargains You Need In Your Retirement Portfolio

These opportunities will not last long, so you need to act fast. These dividend-paying picks out-yield inflation - making them instant wins. Finding opportunities like these is the best route to maximize retirement income. For further details see: 2 Super Dividend Bargai...

HQH - Weekly Closed-End Fund Roundup: November 28, 2021

4 out of 24 CEF sectors positive on price and 2 out of 24 sectors positive on NAV last week. Date for PIMCO merger of PCI and PKO into PDI announced. USA rights offering results. JDD, JTA and JTD have been merged into the multi-asset NMAI. For further details see: We...

HQH - Will The Bull Market Continue In 2022? How To Invest Now?

The S&P 500 has not only fully recovered from the lows of the 2020 pandemic but has added on nearly 45% compared to the beginning of 2020. Will the current bull run continue in 2022, or are we heading towards a cliff? Should you invest now or wait for lower prices? We provide ...

Previous 10 Next 10